Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Hanson

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
Journal of Medical Genetics|December 28, 2023
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory surveySophie Allen, Lucy Loong, Alice Garrett, et al.
American Journal of Human Genetics|June 19, 2018
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor PhenotypesJames Whitworth, Philip S Smith, Jose-Ezequiel Martin, et al.
Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of <i>BRCA1/2</i> pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Journal of Clinical Epidemiology|October 1, 2024
Corrigendum to "Development of an international glossary for clinical guidelines collaboration" "[Journal of Clinical Epidemiology 158 (2023) 84-91]"Rachel E Christensen, Michael D Yi, Bianca Y Kang, et al.
Journal of Clinical Epidemiology|April 5, 2023
Development of an international glossary for clinical guidelines collaborationRachel E Christensen, Michael D Yi, Bianca Y Kang, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
The Lancet. Oncology|November 27, 2022
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk SyndromesJosé Garcia-Pelaez, Rita Barbosa-Matos, Silvana Lobo, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Medical Genetics|November 14, 2019
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic <i>TP53</i> mutation carriers: a case-controlled study (SIGNIFY)Elizabeth K Bancroft, Sibel Saya, Emma Brown, et al.
Journal of Medical Genetics|December 28, 2023
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory surveySophie Allen, Lucy Loong, Alice Garrett, et al.
American Journal of Human Genetics|June 19, 2018
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor PhenotypesJames Whitworth, Philip S Smith, Jose-Ezequiel Martin, et al.
Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of <i>BRCA1/2</i> pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Journal of Clinical Epidemiology|October 1, 2024
Corrigendum to "Development of an international glossary for clinical guidelines collaboration" "[Journal of Clinical Epidemiology 158 (2023) 84-91]"Rachel E Christensen, Michael D Yi, Bianca Y Kang, et al.
Journal of Clinical Epidemiology|April 5, 2023
Development of an international glossary for clinical guidelines collaborationRachel E Christensen, Michael D Yi, Bianca Y Kang, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
The Lancet. Oncology|November 27, 2022
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk SyndromesJosé Garcia-Pelaez, Rita Barbosa-Matos, Silvana Lobo, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Pageof 9